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SUMMARY 
Exposure to astronauts could be a significant obstacle for long duration manned space exploration because of current 
uncertainties regarding the extent of biological effects.  Furthermore, concepts for protective shielding also pose a 
technically challenging issue due to the nature of cosmic radiation and current mass and power constraints with 
modern exploration technology.  As biological damage from exposure is associated with increased oxidative stress, 
it would be enabling to mitigate and/or prevent stress prior to the development of clinical symptoms and disease.  
This paper hypothesizes a “systems biology” approach in which a combination of chemical and biological mitigation 
techniques are used conjunctively.  It proposes using new, therapeutic, medical gases as both chemical 
radioprotectors for radical scavenging and biological promoters for management of the body’s response to exposure.  
From reviewing radiochemistry of water, biological effects of CO, H2, NO, and H2S gas, and mechanisms of 
radiation biology, it is concluded that this approach may have great therapeutic potential for exposure.  Furthermore, 
it also appears to have potential for curtailing the pathogenesis of other diseases in which oxidative stress has been 
implicated including cardiovascular disease, cancer, chronic inflammatory disease, hypertension, 
ischemia/reperfusion injury, acute respiratory distress syndrome, Parkinson’s and Alzheimer’s disease, cataracts, 
and aging. 
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The Challenge of Space Radiation 
Galactic Cosmic Rays (GCR), solar energetic particles (SEP), and trapped energetic particles in a planetary 
magnetic field are natural sources of radiation in space.  GCRs consist of highly energetic nuclei, predominately 
protons and He, but also with trace amounts of C, O, Ne, Si, Ca, and Fe ions.  Particle energies can range from 100 
MeV to 10 GeV per nucleon.  Although the high charge and energy (HZE) nuclei are in trace amounts, they are still 
of concern because they can cause more damage than protons since they are more highly ionizing.  As well, even 
though particle fluencies are typically low, they are chronic and can significantly increase with solar events.  
Furthermore, GCRs and SEPs impinging on shielding material, atmosphere, or surface of a planet or satellite can 
produce secondary radiation, including energetic neutrons, from nuclear fragmentation of the primary ion and target 
atoms.  This can introduce an additional component to the radiation field which makes shielding from HZE quite 
challenging and poses one of the principal unknowns in understanding the effects of HZE effects with human tissue 
[1].  Furthermore, while our bodies do possess a natural repair mechanism, radiation with a high linear energy 
transfer (LET) rate, like space radiation, is attributed to be more likely to cause double strand breaks in DNA that 
are relatively more difficult for our natural repair mechanisms to fix correctly [2].  While a week or month of this 
radiation at the dose rates naturally present likely will not have serious consequences, several year durations in space 
could.   
 
The traditional paradigm for radiation protection is to minimize exposure time, maximize distance from radiation 
sources, and use shielding to attenuate and absorb radiation before it can deposit its energy in humans.  In regards to 
minimizing exposure time, new propulsive technologies could reduce trip times but have yet to be developed and 
would not address the ability to remain at a location for long durations.  It is impractical to maximize distance from 
cosmic radiation sources.  In regards to shielding, aspects of attenuation by mass or deflection by magnetic fields or 
charge repulsion have been considered.  Due to the phenomena of secondary radiation, shielding by other matter 
may require a significant amount of mass which could be impractical within current mass constraints in space 
systems.  Due to the high energy of the space radiation, magnetic field and charge strengths required may be 
unreasonable due to current mass and power constraints in space systems along with other system design 
implications.  In short, shielding space radiation is seemingly quite challenging.  However, advances in biochemistry 
may reveal some more tools for radiation protection [1].   
Parallels between Radiation Biology & Chemistry of Water  
Radiolysis is the decomposition of water from exposure to ionizing radiation.  Radiation chemistry of water has 
been well studied since the onset of nuclear power production, as water has been the most often used coolant.  Since 
mammalian cells are composed of about 80% water, it seemed natural that there exist similarities between radiation 
chemistry of water and radiation biology.  It is these similarities from which analogues for radioprotective measures 
were inspired. 
 
Chain of Events Initiated by Chemically Reactive Species 
 
Radiolysis in nuclear systems causes a chain of events that ultimately manifest into systematic problems like 
corrosion and gas generation.  Ionizing radiation creates chemically reactive radicals H3O+, e-, H+, H, and OH by 
ionizing and/or breaking the bonds of water molecules.  These radicals then initiate a chain of chemical reactions 
within the water which can result in the formation of molecular decomposition products such as H2, O2, HO2 and 
H2O2 [3].  These oxidizing species alter the water composition and therefore its electrochemical character which 
facilitates the manifestation of problems like corrosion or gas generation.  As such, the nature in which systematic 
problems develop can be viewed as stemming from a chain of events that are initiated by ionization and propagated 
by a scheme of chemical reactions depending upon the net result of the ensuing chemistry.   
 
This situation is similar in nature to a biological system and the pathogenesis of radiation related ailments.  
Ionization of key biological molecules can lead to chemical reactions which transform these molecules.  This alters 
their biochemical function and can result in changes of cellular properties.  This propagates from tissue to organ to 
system changes that ultimately manifest into clinical symptoms and ailments.  Ionization of the molecules can occur 
both directly by radiation and indirectly by free radicals and reactive oxygen species (ROS) created by radiolysis.  
Free radicals and ROS like O2-, 1O2, ⋅OH, ⋅OOH, NO⋅ and H2O2 can cause cell injury or death by oxidative stress 
[4,5].  Oxidative stress can result in DNA damage, lipid peroxidation and also lead to a loss of protein after 
reductive remodeling of skeletal muscle due to undernutrition in space [6].  Radiation-induced damage of 
chromosomes in lymphocytes may compromise the immune system’s ability to prevent tumor development [7].  In 
general, the greatest risks from exposure are assumed to be cancer, cataracts, [8] and damage to the central nervous 
system [9].  Interestingly enough, oxidative stress has been implicated to play a role in the development of other 
diseases [10,11] including cardiovascular disease, cancer [12], chronic inflammatory disease [13], hypertension [14], 
ischemia/reperfusion injury [4], acute respiratory distress syndrome (ARDS) [15], neurodegenerative diseases such 
as Parkinson’s disease and Alzheimer’s disease [16,17] and aging [18].  Certain detrimental effects from space 
radiation on the dopaminergic system are similar to functional changes that occur from Parkinson’s disease [9], 
diabetogenic problems associated with increased C-peptide excretion and insulin resistance  [19], as well as 
constipation due to malfunction of intestine.  That is, the normal production and development of these disorders and 
diseases have also been associated with an increase of oxidative stress and inflammation similar to that which would 
likely be caused or increased by exposure to space radiation.  Thus the nature of the problem seems similar to 
nuclear systems in that systematic manifestations result from a chain of events initiated by ionization and 
propagated, in this case, by ensuing chemical reactions and biological responses.   
 
Radical Scavenging & Antioxidants 
The actual chemical reactions that ensue and their by-products depend upon what the radicals come into contact 
with.  For example, in pure water, radical-radical interactions lead to the formation of the decomposition products 
while radical-decomposition product reactions lead to the reformation of water.  In a nuclear system, manifestation 
of system level problems has been curtailed by interfering with the chain of events early on during the chemical 
stages through the use of additives that alter water composition.  Whereas some additives have been found to 
promote and increase water decomposition, others have been found to suppress it [20].  This occurs through 
scavenging in which the additives preferentially react with the radicals.  Scavenging has the effect of removing 
reactive species from the system and thereby reduces their ability to participate in chemical reactions that cause 
decomposition.  While there are various additives that preferentially react with decomposition products, the 
byproducts of the scavenging reaction are a factor as they are part of the composition.  For example, some ionic 
impurities scavenge radicals but do so at the expense of the water reformation process as the consumed radicals are 
no longer available to react with decomposition products in the chemical reactions that lead to water reformation as 
shown in 1-4.   
 OH + Br-  Br + OH- (1) 
 H + Br  Br - + H+ (2) 
 H + Cu++  Br - + H+ (3) 
 OH + Cu+  Cu++ + OH- (4) 
However, the use of hydrogen as a scavenger produces byproducts that promote the water reformation process while 
neutralizing radicals.   
 H2 + OH  H2O + H (5) 
 H + H2O2  H2O + OH (6) 
The ability of H2 to suppress total oxidant concentrations in a water system exposed to radiation has long been 
recognized by the boiling water reactor (BWR) community and is referred to as hydrogen water chemistry (HWC).  
The addition of H2 to water has the effect of suppressing the Open Circuit Potential (OCP) of the water (Fig. 1) 
thereby electrochemically reducing the driving potential for corrosion.   
 
In a biological system, antioxidants have been seen to protect against oxidative stress and prevent the pathological 
process of a wide range of disease [22].  The effect of antioxidants in reducing oxidative stress can be attributed to 
their ability to protect tissues from free radicals [5] hinting towards a scavenging mechanism.  Turner [23] indicates, 
“A number of radiosensitizing chemicals and drugs are known.  Some sensitize hypoxic cells, but have little or no 
effect on normally aerated cells.  Other agents act as radioprotectors reducing biological effectiveness...which 
scavenge free radicals.  Still other chemicals modifiers have little effect on cell killing but substantially enhance 
some multistep processes, such as oncogenic cell transformation.”  Thus it appears that radical scavengers or 
antioxidants act as radioprotectors that chemically protect against indirect ionization by preferentially reacting with 
the reactive species thus reducing their ability to cause oxidative stress.   
 
This dependency of outcome on scavenger type is similar to nuclear systems where the effect of the additive can 
either be to promote water decomposition or water reformation.  One such example is the effect of oxygen.  There 
appear to be parallels in the effect of oxygen to promote water decomposition in a nuclear system and increased 
radiosensitivity of cells in the presence of oxygen as shown in Fig. 2C.  Fig. 2D also includes the effect of hydrogen 
and shows that when in excess of ROS like O2 and H2O2, the water reformation process dominates as ROS are 
quickly scavenged.  This begs the question of what the effect of H2 would be on radiosensitivity.  Also noteworthy 
in fig. 2 is the occurrence of an equilibrium where the amount of molecular decomposition byproducts from 
radiolysis remains constant.  This reflects a balance between water decomposition and reformation process and hints 
at the ability for radical scavengers to affect which process dominates.   
The Net Effect of Competing Processes & Natural Repair Mechanisms 
Radiolysis of water results in chemical reactions that are part of two competing processes:  decomposition and 
reformation.  Decomposition will still occur even in the presence of additives but they serve to alter the net effect by 
affecting the chemical reactions such that one process becomes more dominate.  This was seen somewhat in fig. 2 
and is shown more explicitly in fig. 3 which shows that the threshold for which negative effects can manifest can be 
increased through bolstering the scavenging capacity and altering the balance so that the favorable processes are 
dominant.  
 
Free radicals and ROS were identified as the root cause of oxidative stress in a biological system.  While free 
radicals and ROS are created from exposure to external sources like X-rays, ozone, cigarette smoke, air pollutants 
and industrial chemicals [25], they also are naturally generated during a variety of energy-generating biochemical 
reactions and cellular functions [4].  Furthermore, the ROS actually serve a necessary function as signaling 
molecules that critically modulate the activation of the immune system and thus participate in antibacterial defense 
[26].  Oxidative stress occurs when there is an imbalance between antioxidants and ROS and free radicals [28] such 
as when radiation exposure increases the amount of free radicals and ROS through production by ionization.  Thus, 
in the biological system, it similarly appears to be a situation of competing processes between biochemical damage 
and repair processes.  Chopping observes, “The cell is protected by different DNA repair mechanisms which try to 
restore the damage.   We don’t know the details, except when the repair goes wrong (e.g. a replacement of a lost 
nucleotide by a ‘wrong” base pair, etc.)… The cell contains natural radical scavengers.  As long as they are in excess 
of the radiolysis products, the DNA may be protected.  When the products exceed the amount of scavengers, 
radiation damage and cancer induction may occur.  In principle, there could thus be a threshold dose for radiation 
damage, at which the free radicals formed exceed the capacity of scavenging.  The scavenging capacity may differ 
from individual to individual depending on his/her physical condition” [2].  Experimental investigations regarding 
long-duration space flights in particular clearly showed increased oxidative stress markers and a reduction in 
antioxidants after these flights [29, 6].  Kennedy et al. demonstarted that exposure to space radiation may 
compromise the capacity of the host antioxidant defense system and that this adverse biological effect can be 
prevented, at least partially, by dietary supplementation with agents expected to have effects on antioxidant activities 
[30].  Interestingly and similarly so, the radiation resistance of the bacteria Deinococcus radiodurans that can grow 
under chronic γ radiation (50 Gy/hr) or recover from acute doses greater than 10 kGy has been attributed to the role 
of antioxidants in mitigating the extent of oxidative damage [31-33].  Thus there appear to be similarities between 
the nuclear and biological systems in how use of scavengers can enhance and bolster the favorable process thereby 
increasing the natural radiation resistance of the system.  Thus, a strategy that (1) interrupts the chain of events 
leading to biological disease and (2) bolsters natural repair processes and reduces damage processes could have a 
great effect on increasing the threshold after which radiation damage propagates to the systematic symptoms.   
 
Radiation protection by a biochemical conjunctive approach 
Over the course of the last century, a wealth of knowledge has been accumulated on the effect of radiation on 
biological systems.  Areas spanning in scope from DNA damage up to changes in physiology have received 
extensive study. To date, biology studies of radiation damage have largely focused on components of DNA repair 
systems such ataxia telangiectasia mutated gene (ATM).  More recently, however, it has been found that 
modification of key molecular targets can protect tissue from radiation induced fibrosis in mice exposed to doses up 
to 25Gy [34,35].   It has also been found that changes in APOE (Apolipoprotein E) genotype dramatically influences 
survival following Total Body Irradiation (TBI) in murine models. These results imply that modification of key 
molecular targets to induce biological changes in the host can protect tissue from radiation damage.  The use of new, 
therapeutic medical gases as gaseous antioxidants and biological promoters/ ‘signaling’ molecules, working 
conjunctively, may be effective in preventing, protecting, and repairing radiation damage.  Turner notes that, “for 
carcinogensis or transformation, for example, such biological promoters (radioprotectors) can dwarf the effects of 
physical factors, such as LET and dose rate, on dose-response relationships” [23].   
 
Radioprotectors have been implicated to work by the following chemical and biological mechanisms: 
1. radical scavenging of toxic decomposition products of free radicals and ROS 
2. repair of biological molecules by donation of H atoms, as seen in polymers, since hydrogen bonds are 
among the weakest in biological molecules and such are the first to be broken [36] 
3. interaction with cellular components (binding, altering metabolic pathway, etc.)  
Interaction with cellular components can have biological effects that lend to radioprotection like hypoxia, alteration 
of metabolic state, and anti-apoptotic and anti-inflammatory properties.  Tissue hypoxia decreases the 
radiosensitivity of cells by minimizing the O2 effect and can be produced chemically by impairing oxygen transport 
(binding up hemogloblin with another molecule) or biologically by restricting blood flow (vasoconstrictor drug) or 
lowering blood pressure (vasodilator drug).  Inducing a hypometabolic state which resembles hibernation, may 
contribute to tolerance against oxidative stress.  Metabolic rates in hibernating marmots and ground squirrels help 
delay the onset of obvious damage.  Also, survival times for guinea pigs that have received massive doses of 
radiation (>6000 rads) have been extended from several hours to about 4 days through the use of central nervous 
system depressants (pentobarbital) where it has been attributed to partial protection from central nervous system 
syndrome [36].  Furthermore, a hypometabolic status may also prove to be an ideal therapy for various shock or 
trauma states in which dramatic reduction in metabolic demands may be highly protective [37].  Anti-apoptotic 
properties can mitigate organ damage such as in IR injury by reducing the amount of cellular self destruction.   
Interference with mitosis and DNA synthesis can slow cells in their radio-resistant phase of cell division and afford 
more time for natural repair of the cell prior to replication of the damage.  NO, CO, H2S and H2 are gaseous 
signaling molecules in humans.  These molecules act as transmitters of information between cells by chemically 
interacting with cell receptors to trigger a response within the cell.  These comprise some of the medical gases of 
interest and many of them act both on the chemical level in the form of antioxidant radical scavenging and on the 
biological level in the form anti-inflammatory, anti-apoptotic, and other biological effects.  Extensive and more 
detailed information about these gases in a therapeutic role can be found in [22] which provides a detailed 
description of medical gases of interest and their properties and [38] provides detailed information pertaining in 
particular to H2.   
 
Hydrogen 
Hydrogen has only recently been considered for therapeutic applications for radiation exposure [39, 40] and recent 
results have demonstrated its radioprotective effects in cultured cells and mice [41].  Hydrogen properties as a 
medical gas are summarized in Table 1.  Hydrogen may have potential as a safe and potent therapeutic medical gas, 
as well as several potential advantages over current pharmacological therapies for the following reasons:  
• It is highly diffusible and as such could potentially reach subcellular compartments, such as mitochondria 
and nuclei, which are the primary site of ROS generation and DNA damage [42] and are also notoriously 
difficult to target pharmacologically.   
• Its hyporeactivity with other gases at therapeutic concentrations may allow hydrogen to be administered 
with other therapeutic gases, including inhaled anaesthesia agents [43]. 
• H2 may spare the innate immune system while still allowing phagocytosis of infecting organisms.  When 
tested in vitro, it did not eliminate O2- or H2O2 which have important functions in neutrophils and 
macrophages as they must generate ROS in order to kill some types of bacteria engulfed by phagocytosis 
[42].  It is not clear whether a similar reaction preferentially occurs under complex biological conditions.  
Experimental studies have demonstrated that hydrogen has potent therapeutic efficacies on both parasite 
infection [44] and polymicrobial sepsis [45]. 
• No adverse effects have been found in humans drinking hydrogen water in a study that examined the 
effects of drinking hydrogen-rich water (HW) for radiation-induced late adverse effects [46, 47].  Studies 
showed that the consumption of HW for 6 months resulted in significant decrease of serum levels of 
derivatives of Reactive Oxidative Metabolites (dROMs) and an increase of biological antioxidant power 
determined by Free Radical Analytical System (FRAS). No severe adverse effects were seen during follow 
up period.  These results suggest that drinking HW improved Quality of Life (QOL), associated with 
decrease of oxidative injury markers, in patients with radiotherapy. 
 
Nitric Oxide   
Medical properties for NO are summarized in Table 2 and effects are shown in Fig. 4.  NO regulates platelet 
activity, preservation of the normal structure of the vessel wall and causes blood vessel dilation which may increase 
tissue blood supply [22].  This could abate inflammatory response and thus protect tissue from oxidative injury.  It 
also may enhance the natural repair as mechanism as it is believed to be more effective in a living organism, where 
the cells are in continuous exchange with the surrounding cells and body fluids, than in the tissue samples often 
studied in the laboratory [2].  Results from NO studies that have examined the ability of patients to inhale NO to 
improve outcome of acute respiratory distress syndrome (ARDS) have had discrepant results from positive, negative 
or neutral outcomes.  Thus NO may be linked with both protective and toxic effects depending upon concentrations, 
source, timing of administration and the environment suggesting a narrow window for administration in the 
treatment of oxidative injuries [48].  Reduction of excessive and deleterious NO effects appear to be controlled by 
blocking NO/cGMP signaling through thrombospondin-1 signaling via its receptor CD47.  This has shown to both 
maintain the viability of normal tissues against radiation induced fibrosis in murine models following total body 
irradiation (25 Gy) and increase the radiosensitivity of tumors [34, 49, 35].  
  
Carbon Monoxide  
Table 3 summarizes medical properties of CO gas.  While the adverse effects of inhaled CO are a major concern for 
clinical use, experimental models have demonstrated that potent therapeutic efficacies exist at low concentrations 
[22, 50].  Soluble forms of CO, such as CO-releasing molecules, may overcome the problem of tissue hypoxia and 
allow clinical application [51, 52].  Recent animal studies have shown discrepant results between exhibiting and not 
exhibiting anti-inflammatory effects [22].  These discrepancies may be attributed to species specific differences in 
the affinity of CO for hemoglobin, or physiological differences such as respiratory rate and sensitivity to 
lipopolysaccharides (endotoxins) [53, 54].  Fig. 5 shows that administration of H2/CO mixtures has been shown to 
reduce structural damage to hearts in Lewis rats undergoing heart transplantation (HTx) in which oxidative stress 
injury is caused by ischemia/reperfusion [22] rather than radiation exposure. 
Hydrogen Sulfide 
H2S is produced enzymatically at micromolar levels in mammals and is believed to help regulate body temperature 
and metabolic activity at physiological concentrations [55, 56].  It has been implicated as the mechanism by which 
consumption of garlic attenuated cardiovascular disease where production of the gas has been demonstrated to occur 
by bioconversion of garlic-derived polysulfides by red blood cells [56].  According to Lefer [37], it appears that H2S 
possesses all of the positive effects of NO without the capacity to form the toxic metabolite such as ONOO-.   The 
medical properties of H2S are summarized in Table 4.   
 
Possible administration methods 
Hydrogen or combinations of other medical gases could be administered to astronauts by inhalation, ingestion or 
injection.  Inhalation could be achieved though a ventilator circuit, facemask, nasal cannula, or creating a spacesuit 
or spacecraft atmosphere which is composed of or contains a non-flammable gas mixture of these therapeutic 
medical gases.  The use of Hydreliox, an exotic breathing gas mixture of 49% hydrogen, 50% helium and 1% 
oxygen for prevention of decompression sickness and nitrogen narcosis during very deep technical diving [57] is 
one example of human inhalation of hydrogen gas mixtures.  Drinking hydrogen-rich water (HW) appears to have 
comparable effects to hydrogen inhalation [58].  Although inhaled hydrogen gas may act more rapidly, oral intake of 
hydrogen-rich water is another method which may be more practical for daily life or suitable for continuous 
consumption in preventive or therapeutic uses.  Ingestion of gas dissolved solutions may prove to be more portable, 
easily administered, and a safe means of delivering molecular hydrogen [59].  Gas rich water in which the gases 
have been dissolved could be prepared by bubbling gases into solution under pressure or other dissolution methods 
like swept gas diffusion.  However, consideration will have to be given to loss of gas over time by dissolution and 
diffusion.  Alternatively, some therapeutic gases such as hydrogen could be generated in solution by chemical 
reaction with the solution such as magnesium (Mg + 2H2O  Mg(OH)2 + H2).  In this case for example, a magnesium 
stick could be inserted into the water just prior to drinking.  However, consideration will also have to be given to 
ingestion of other produced byproducts.  Though oral administration is safe and convenient, hydrogen can be lost 
from solution by dissolution and diffusion and some hydrogen is lost in the stomach or intestine, making it difficult 
to control the concentration of hydrogen administrated. Administration of hydrogen via an injectable hydrogen-rich 
solution may allow delivery of more accurate concentrations of hydrogen [60].  This method of administration has 
been demonstrated for hydrogen in mice [41]. 
 
CONCLUSIONS 
A systems approach for radioprotection has been hypothesized.  It is suggested that various therapeutic medical 
gases can be used as chemical radioprotectors and biological signaling molecules to disrupt the chain of events 
initiated by radiation exposure and interfere with pathogenesis of disease.  This could have a profound positive 
effect as it addresses prevention, protection, and repair.  This represents a novel and feasible 
preventative/therapeutic strategy to address radiation-induced adverse events and thus the challenge of space 
radiation.  While more studies are warranted to apply this therapy for space travel and determine details of optimum 
gas mixtures and therapy administration plans, it appears that it represents a potentially novel, therapeutic, and 
preventative strategy that may also ameliorate symptoms for other oxidative stress related diseases as has been 
shown in relevant ground-based (animal) models. 
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TABLES  
TABLE 1. Cited Properties of H2
Biochemical Mechanism 
 as a Medical Gas with Suggested Chemical/Biological Mechanisms.  
Notes 
radical scavenging antioxidant • selectively reduces hydroxyl radicals (•OH) and peroxynitrite (ONOO--)  
but did not eliminate O2- or H2O2
• does not decrease the steady-state levels of nitric oxide (NO) [42] which 
may be beneficial as endogenous NO signaling pathways modulate 
pulmonary vascular tone and leukocyte/endothelial interactions [61]. 
 when tested in  in vitro [42]. 
• increases antioxidant enzymes such as catalase, superoxide 
dismutase or heme oxygenase-1 [45,46]. 
anti-apoptotic • postulated to inhibit caspase-3 activation [62]. 
anti-inflammatory • down-regulation of pro-inflammatory cytokines, such as interleukin 
(IL)-1 β, IL-6, chemokine (CC motif) ligand 2 and tumor necrosis 
factor-α (TNF-α) [63,64]. 
 
TABLE 2. Cited Properties of NO as a Medical Gas with Suggested Chemical/Biological Mechanisms. 
 
Biochemical Mechanism Notes 
radical scavenging antioxidant • NO reacts with peroxy and oxy radicals generated during the 
process of lipid peroxidation.  The reactions between NO and these 
ROS can terminate lipid peroxidation and protect tissues from 
ROS-induced injuries [65]. 
• induces the rate-limiting antioxidant enzyme, heme oxygenase 
(HO)-1 thus imparting resistance to H2O2 
• in bacteria, activates the redox-sentive transcriptional regulator 
protein (oxyR), resulting in the subsequent expression of protein 
protective against ROS [67]. 
induced cell death  [66]. 
anti-inflammatory • inhibiting P-selectin expression and leukocyte recruitment [68].   
decreased radiosensitivity • vasodilator through relaxation of vascular tone by stimulating 
soluble guanylate cyclase (sGC) and increased cGMP content in 
vascular smooth muscle cells [22]. 
TABLE 3. Cited Properties of CO as a Medical Gas with Suggested Chemical/Biological Mechanisms. 
 
TABLE 4. Cited Properties of H2
Biochemical Mechanism 
S as a Medical Gas with Suggested Chemical/Biological Mechanisms. 
Notes 
radical scavenging antioxidant • binds to the heme moiety of mitochondrial cytochrom c oxidase.  By 
binding to the heme, CO may prevent degradation of heme proteins which 
induce tissue injury by rapidly promoting peroxidation of the lipid 
membranes of cells [69, 70]. 
• reduces mitochondria-derived ROS thus resulting in lower levels of ROS 
generation in which an adaptive cellular response is triggered leading to 
cell survival rather than cell death [71-73]. 
• can induce HO-1 in cells to protect against injury [74-76].  Thus, 
detrimental excess of heme can be immediately removed by HO-1 
enzymatic activity induced by CO. 
decrease radiosensitivity • impedes O2 transport as it binds to hemoglobin with an affinity 240 times 
higher than that of O2
Biochemical Mechanism 
. 
Notes 
radical scavenging antioxidant • antioxidant inhibitor of peroxynitrite-mediated processes via activation of 
N-methly-D-aspartate (NMDA) receptors [77]. 
• shield cultured neurons from oxidative damage by increasing levels of 
glutathione [78]. 
• induce upregulation of HO-1, anti-inflammatory and cytoprotective genes 
[79, 80].   
• inhibits myeloperoxidase and destroys H2O2
anti-apoptotic 
 [81].   
• reduces IR induced apoptosis via reduction of cleaved caspase-3 
and cleaved poly (ADP-ribose) polymerase (PARP) [82].  
anti-inflammatory • inhibit leukocyte adherence in the rat mesenteric microcirculation 
during vascular inflammation [37].   
decrease radiosensitivity • vascorelaxtion and vasodilation of isolated blood vessels via vascular 
smooth muscle KATP
• transiently and reversibly inhibiting mitochondrial respiration [37]. 
 channel-mediated hyperpolarization [37, 22]. 
metabolic alteration  • produces a “suspended animation-like” metabolic status with hypothermia 
and reduced oxygen demand in pigs (who received it intravenously) [83]. 
and mice (who received hydrogen sulfide via inhalation) [84, 85]. 
FIGURES AND CAPTIONS 
 
FIGURE 1.  The Effect on OCP of the Solution From H2 Gas Bubbled Into it and the Addition of 0.1 M H2O2 as Measured by 
Tungsten/Tungsten-Oxide (ref. electrode) and Platinum Electrodes (vs. Saturated Calomel Electrode SCE) [21]. 
 
 
FIGURE 2.  (A)-(D) [24] Reflect Water Decomposition by the Concentration of Radiolysis byproducts.  (B) is an Extension of 
(A) and is Air Free Pure Water.  Decomposition Ensues until H2 in Excess of ROS.  (C) is Effect of Dissolved O2 in Excess of H2 
to Promote Decomposition.  (D) is Effect of Dissolved Hydrogen in Excess of O2 to Scavenge.  (E) [23] Shows Effect of O2 as a 
Biological Radiosensitizer.  N2 is Also Shown Which Begs the Question of the Effect of H2. 
 
 FIGURE 3.  Relative Contribution of the Water Decomposition Process is Associated with Boric Acid Concentration Measured 
in Milli-molar on the Abscissa.  System Scavenging Capacity or Relative Contribution of the Water Reformation Process is 
Associated with the Initial Amount of Dissolved H2 Measured in Micro-molar Concentrations (each curve).  Manifestation of 
Negative Systematic Effects is Reflected by the Amount of Water Decomposition from Radiolysis as Reflected by H2 Gas 
Generation Rates Measured in Micro-molar Concentrations per Minute on the Ordinate.  Figure Illustrates That the Addition of 
dissolved H2 Increases the Scavenging Capacity of the Water Therefore Increasing the Threshold and Delaying the Onset of 
when Decomposition Becomes the Dominant Process [27]. 
 
FIGURE 4.  Images Compare Treated and Untreated Hind Limbs 8 Weeks After An Exposure of 25 Gy Showing That 
Signs of Fibrotic Contractures Occurred Only in the Untreated Limb [49]. 
 
 
FIGURE 5.  Extent of Gross Structural Damage to Heart Graft Was Evaluated by TTC staining 3 h After Reperfusion.  H2 and 
CO Inhalation Reduced Ischemic Area Following Heart Grafts but with Only Slight Significance.  Significant Reduction is Seen 
by Dual Treatment [22].  
